Houssein Safa

811 total citations
16 papers, 468 citations indexed

About

Houssein Safa is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, Houssein Safa has authored 16 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Surgery and 4 papers in Cancer Research. Recurrent topics in Houssein Safa's work include Cancer Immunotherapy and Biomarkers (9 papers), CAR-T cell therapy research (5 papers) and Genital Health and Disease (4 papers). Houssein Safa is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), CAR-T cell therapy research (5 papers) and Genital Health and Disease (4 papers). Houssein Safa collaborates with scholars based in United States, Egypt and Italy. Houssein Safa's co-authors include Adi Diab, Noha Abdel‐Wahab, María E. Suarez‐Almazor, Daniel H. Johnson, Heather Lin, Van Anh Trinh, Michael K. Wong, Ala Abudayyeh, Chrystia M. Zobniw and A. Osama Gaber and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Houssein Safa

16 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Houssein Safa United States 6 353 97 86 83 58 16 468
Lajhem Cambridge United States 6 516 1.5× 53 0.5× 191 2.2× 130 1.6× 96 1.7× 8 603
Omar Mamlouk United States 9 344 1.0× 17 0.2× 158 1.8× 20 0.2× 69 1.2× 33 476
Xerxes Pundole United States 11 231 0.7× 21 0.2× 59 0.7× 41 0.5× 46 0.8× 38 359
JR Schriber United States 8 212 0.6× 62 0.6× 26 0.3× 16 0.2× 108 1.9× 9 528
S. D. Rowley United States 8 139 0.4× 56 0.6× 58 0.7× 20 0.2× 45 0.8× 11 436
Pankti Reid United States 12 233 0.7× 26 0.3× 71 0.8× 35 0.4× 60 1.0× 42 358
Geundoo Jang South Korea 12 208 0.6× 27 0.3× 159 1.8× 14 0.2× 37 0.6× 39 396
Diana Almader‐Douglas United States 11 175 0.5× 13 0.1× 88 1.0× 72 0.9× 17 0.3× 30 442
Caroline Lum Australia 8 309 0.9× 73 0.8× 80 0.9× 126 1.5× 14 0.2× 13 398
Alessio Pellegrinelli Italy 14 364 1.0× 188 1.9× 93 1.1× 284 3.4× 19 0.3× 23 519

Countries citing papers authored by Houssein Safa

Since Specialization
Citations

This map shows the geographic impact of Houssein Safa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Houssein Safa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Houssein Safa more than expected).

Fields of papers citing papers by Houssein Safa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Houssein Safa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Houssein Safa. The network helps show where Houssein Safa may publish in the future.

Co-authorship network of co-authors of Houssein Safa

This figure shows the co-authorship network connecting the top 25 collaborators of Houssein Safa. A scholar is included among the top collaborators of Houssein Safa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Houssein Safa. Houssein Safa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Safa, Houssein, et al.. (2024). Overview of Systemic Therapies in Penile Cancer. Urologic Clinics of North America. 51(3). 347–354. 1 indexed citations
2.
Safa, Houssein, Jacob J. Adashek, Filip Ionescu, et al.. (2024). 15 years of patient-reported outcomes in clinical trials leading to GU cancer drug approvals: a systematic review on the quality of data reporting and analysis. EClinicalMedicine. 68. 102413–102413. 12 indexed citations
3.
Safa, Houssein, et al.. (2024). Immune-based Therapies for Penile Cancer. Urologic Clinics of North America. 51(3). 355–365. 2 indexed citations
4.
Safa, Houssein, et al.. (2024). Insights into the management of penile squamous cell carcinoma: from conventional approaches to emerging novel therapies. Expert Opinion on Pharmacotherapy. 25(4). 447–465. 2 indexed citations
5.
Ionescu, Filip, Houssein Safa, G. Daniel Grass, et al.. (2023). The Prognostic Role of Human Papillomavirus and p16 Status in Penile Squamous Cell Carcinoma—A Systematic Review. Cancers. 15(14). 3713–3713. 14 indexed citations
6.
Reid, Pankti, Sabina Sandigursky, Juhee Song, et al.. (2023). Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases. OncoImmunology. 12(1). 2261264–2261264. 3 indexed citations
7.
Bentebibel, Salah-Eddine, Daniel Johnson, Barbara Pazdrak, et al.. (2022). 782 Intratumoral sotigalimab with pembrolizumab activates antigen-presenting cells and induces local and distant anti-tumor responses in first-line metastatic melanoma: results of a phase I/II study. Regular and Young Investigator Award Abstracts. A814–A814. 2 indexed citations
8.
Safa, Houssein, et al.. (2022). Emerging Biomarkers in Immune Oncology to Guide Lung Cancer Management. Targeted Oncology. 18(1). 25–49. 4 indexed citations
9.
10.
Safa, Houssein, et al.. (2020). Difficulties in Differentiating Between Checkpoint Inhibitor Pneumonitis and Lung Metastasis in a Patient with Melanoma. Immunotherapy. 12(5). 293–298. 4 indexed citations
11.
Sandigursky, Sabina, Houssein Safa, Xerxes Pundole, et al.. (2020). 658 Toxicities of single agent and combination immune checkpoint inhibitors in patients with pre-existing autoimmune diseases. SHILAP Revista de lepidopterología. A395.1–A395. 3 indexed citations
12.
Safa, Houssein, Philippe E. Spiess, Brandon J. Manley, et al.. (2020). Patient-Reported Outcomes in Clinical Trials Leading to Cancer Immunotherapy Drug Approvals From 2011 to 2018: A Systematic Review. JNCI Journal of the National Cancer Institute. 113(5). 532–542. 28 indexed citations
13.
Abdel‐Wahab, Noha, Houssein Safa, Ala Abudayyeh, et al.. (2019). Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature. Journal for ImmunoTherapy of Cancer. 7(1). 106–106. 187 indexed citations
14.
Safa, Houssein, Daniel H. Johnson, Van Anh Trinh, et al.. (2019). Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature. Journal for ImmunoTherapy of Cancer. 7(1). 319–319. 194 indexed citations
15.
Abdel‐Wahab, Noha, Houssein Safa, Ala Abudayyeh, et al.. (2019). Corrections to: Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature. Journal for ImmunoTherapy of Cancer. 7(1). 4 indexed citations
16.
Safa, Houssein & Isabella C. Glitza Oliva. (2019). Cardiac Metastases in Melanoma. New England Journal of Medicine. 380(9). 858–858. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lajhem Cambridge Breakdown of academic impact, for papers by Omar Mamlouk Breakdown of academic impact, for papers by Xerxes Pundole Breakdown of academic impact, for papers by JR Schriber Breakdown of academic impact, for papers by S. D. Rowley Breakdown of academic impact, for papers by Pankti Reid Breakdown of academic impact, for papers by Geundoo Jang Breakdown of academic impact, for papers by Diana Almader‐Douglas Breakdown of academic impact, for papers by Caroline Lum Breakdown of academic impact, for papers by Alessio Pellegrinelli
Rankless by CCL
2026